ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell... ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.04 | 1.67364016736 | 2.39 | 2.57 | 2.21 | 3258559 | 2.43271732 | CS |
4 | 0.03 | 1.25 | 2.4 | 2.57 | 2.07 | 1192524 | 2.41132473 | CS |
12 | -0.03 | -1.21951219512 | 2.46 | 2.59 | 1.58 | 687061 | 2.34539902 | CS |
26 | 1 | 69.9300699301 | 1.43 | 4.44 | 1.4081 | 835509 | 2.60183915 | CS |
52 | -2.36 | -49.2693110647 | 4.79 | 4.98 | 1.12 | 812061 | 2.28270747 | CS |
156 | -6.97 | -74.1489361702 | 9.4 | 14.19 | 1.12 | 477413 | 4.04068032 | CS |
260 | -6.97 | -74.1489361702 | 9.4 | 14.19 | 1.12 | 477413 | 4.04068032 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.